Tegobuvir
Tegobuvir is a specific, covalent inhibitor of the HCV NS5B polymerase.
Product Specifications
CAS Number
1000787-75-6
Product Name Alternative
GS 333126; GS-9190
UNSPSC
12352005
Hazard Statement
H302, H315, H320, H335
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Tegobuvir.html
Purity
98.01
Solubility
DMSO : ≥ 50 mg/mL
Smiles
FC1=CC=CC=C1C2=NC3=CN(CC4=NN=C(C5=CC=C(C(F)(F)F)C=C5C(F)(F)F)C=C4)C=CC3=N2
Molecular Formula
C25H14F7N5
Molecular Weight
517.40
Precautions
H302, H315, H320, H335
References & Citations
[1]Bae AS, et al. Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples.
 J Clin Microbiol. 2011 Sep;49 (9) :3168-74.|[2]Hebner CM, et al. The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.
 PLoS One. 2012;7 (6) :e39163.|[3]Wong KA, et al. Tegobuvir (GS-9190) potency against HCV chimeric replicons derived from consensus NS5B sequences from genotypes 2b, 3a, 4a, 5a, and 6a.
 Virology. 2012 Jul 20;429 (1) :57-62.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EM23268 96 Tests
Mouse FABP7 (Fatty Acid Binding Protein 7, Brain) ELISA Kit
Sign In for Pricing
View Details